Our evolving understanding of how 27-hydroxycholesterol influences cancer
- 1 February 2022
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 196, 114621
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute (R01CA234025)
- National Institute of General Medical Sciences (R35GM122530)
- National Institutes of Health
- U.S. Department of War (W81XWH-20-BCRP-EOHS / BC200206)
This publication has 138 references indexed in Scilit:
- Cholesterol modulates cell signaling and protein networking by specifically interacting with PDZ domain-containing scaffold proteinsNature Communications, 2012
- Oxysterols direct immune cell migration via EBI2Nature, 2011
- 27-Hydroxycholesterol: the first identified endogenous SERMTrends in Endocrinology & Metabolism, 2011
- Lipid Rafts As a Membrane-Organizing PrincipleScience, 2010
- Estrogen Receptor Signaling in Lung CancerSeminars in Oncology, 2009
- 27-Hydroxycholesterol: a potential endogenous regulator of estrogen receptor signalingTrends in Pharmacological Sciences, 2008
- LXR Signaling Couples Sterol Metabolism to Proliferation in the Acquired Immune ResponseCell, 2008
- Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivorsBreast Cancer Research and Treatment, 2007
- Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: Oxysterols block transport by binding to InsigProceedings of the National Academy of Sciences, 2007
- Parallel SUMOylation-Dependent Pathways Mediate Gene- and Signal-Specific Transrepression by LXRs and PPARγMolecular Cell, 2007